Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi Syndrome

  1. Valéry Matarazzo  Is a corresponding author
  2. Laura Caccialupi
  3. Fabienne Schaller
  4. Yuri Shvarev
  5. Nazim Kourdougli
  6. Alessandra Bertoni
  7. Clément Menuet
  8. Nicolas Voituron
  9. Evan Deneris
  10. Patricia Gaspar
  11. Laurent Bezin
  12. Pascale Durbec
  13. Gérard Hilaire
  14. Françoise Muscatelli  Is a corresponding author
  1. Institut de Neurobiologie de la Méditerranée, France
  2. Karolinska Institutet, Sweden
  3. UFR STAPS, Université Paris 13, France
  4. Case Western Reserve University, United States
  5. INSERM, U839, Institut du Fer à Moulin, France
  6. Lyon Neuroscience Research Center, France
  7. Aix Marseille University CNRS, France

Abstract

Prader-Willi syndrome (PWS) is a genetic neurodevelopmental disorder that presents with hypotonia and respiratory distress in neonates. The Necdin-deficient mouse is the only model that reproduces the respiratory phenotype of PWS (central apnea and blunted response to respiratory challenges). Here, we report that Necdin deletion disturbs the migration of serotonin (5-HT) neuronal precursors, leading to altered global serotonergic neuroarchitecture and increased spontaneous firing of 5-HT neurons. We show an increased expression and activity of 5-HT Transporter (SERT/Slc6a4) in 5-HT neurons leading to an increase of 5-HT uptake. In Necdin-KO pups, the genetic deletion of Slc6a4 or treatment with Fluoxetine, a 5-HT reuptake inhibitor, restored normal breathing. Unexpectedly, Fluoxetine administration was associated with respiratory side effects in wild-type animals. Overall, our results demonstrate that an increase of SERT activity is sufficient to cause the apneas in Necdin-KO pups, and that Fluoxetine may offer therapeutic benefits to PWS patients with respiratory complications.

Article and author information

Author details

  1. Valéry Matarazzo

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    For correspondence
    valery.matarazzo@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0833-203X
  2. Laura Caccialupi

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Fabienne Schaller

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Yuri Shvarev

    Department of Women's and Children's Health, Karolinska Institutet, Solna, Sweden
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6622-1453
  5. Nazim Kourdougli

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8725-792X
  6. Alessandra Bertoni

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Clément Menuet

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7419-6427
  8. Nicolas Voituron

    UFR STAPS, Université Paris 13, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2092-4900
  9. Evan Deneris

    Department of Neurosciences, Case Western Reserve University, Cleveland, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Patricia Gaspar

    INSERM, U839, Institut du Fer à Moulin, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4217-5717
  11. Laurent Bezin

    CNRS, Lyon Neuroscience Research Center, Lyon, France
    Competing interests
    The authors declare that no competing interests exist.
  12. Pascale Durbec

    IBDM UMR7288, Aix Marseille University CNRS, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9660-1809
  13. Gérard Hilaire

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    Competing interests
    The authors declare that no competing interests exist.
  14. Françoise Muscatelli

    INSERM U901, Institut de Neurobiologie de la Méditerranée, Marseille, France
    For correspondence
    francoise.muscatelli@inserm.fr
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4001-6528

Funding

Institut National de la Santé et de la Recherche Médicale

  • Valéry Matarazzo
  • Laura Caccialupi
  • Fabienne Schaller
  • Nazim Kourdougli
  • Alessandra Bertoni
  • Clément Menuet
  • Patricia Gaspar
  • Françoise Muscatelli

Centre National de la Recherche Scientifique

  • Laurent Bezin
  • Pascale Durbec
  • Gérard Hilaire
  • Françoise Muscatelli

Agence Nationale de la Recherche (PRAGEDER ANR14-CE13-0025-01)

  • Valéry Matarazzo
  • Fabienne Schaller
  • Yuri Shvarev
  • Clément Menuet
  • Nicolas Voituron
  • Gérard Hilaire
  • Françoise Muscatelli

Stiftelsen Frimurare Barnhuset i Stockholm

  • Yuri Shvarev

Kronprinsessan Lovisas Forening for Barnasjukvard

  • Yuri Shvarev

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: Mice were handled and cared for in accordance with the Guide for the Care and Use of Laboratory Animals (N.R.C., 1996) and the European Communities Council Directive of September 22th 2010 (2010/63/EU, 74). Experimental protocols were approved by the Institutional Ethical Committee guidelines for animal research with the accreditation no. B13-055-19 from the French Ministry of Agriculture.

Copyright

© 2017, Matarazzo et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,384
    views
  • 252
    downloads
  • 27
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Valéry Matarazzo
  2. Laura Caccialupi
  3. Fabienne Schaller
  4. Yuri Shvarev
  5. Nazim Kourdougli
  6. Alessandra Bertoni
  7. Clément Menuet
  8. Nicolas Voituron
  9. Evan Deneris
  10. Patricia Gaspar
  11. Laurent Bezin
  12. Pascale Durbec
  13. Gérard Hilaire
  14. Françoise Muscatelli
(2017)
Necdin shapes serotonergic development and SERT activity modulating breathing in a mouse model for Prader-Willi Syndrome
eLife 6:e32640.
https://doi.org/10.7554/eLife.32640

Share this article

https://doi.org/10.7554/eLife.32640

Further reading

    1. Neuroscience
    Lenia Amaral, Xiaosha Wang ... Ella Striem-Amit
    Research Article

    Research on brain plasticity, particularly in the context of deafness, consistently emphasizes the reorganization of the auditory cortex. But to what extent do all individuals with deafness show the same level of reorganization? To address this question, we examined the individual differences in functional connectivity (FC) from the deprived auditory cortex. Our findings demonstrate remarkable differentiation between individuals deriving from the absence of shared auditory experiences, resulting in heightened FC variability among deaf individuals, compared to more consistent FC in the hearing group. Notably, connectivity to language regions becomes more diverse across individuals with deafness. This does not stem from delayed language acquisition; it is found in deaf native signers, who are exposed to natural language since birth. However, comparing FC diversity between deaf native signers and deaf delayed signers, who were deprived of language in early development, we show that language experience also impacts individual differences, although to a more moderate extent. Overall, our research points out the intricate interplay between brain plasticity and individual differences, shedding light on the diverse ways reorganization manifests among individuals. It joins findings of increased connectivity diversity in blindness and highlights the importance of considering individual differences in personalized rehabilitation for sensory loss.

    1. Computational and Systems Biology
    2. Neuroscience
    Gabriel Loewinger, Erjia Cui ... Francisco Pereira
    Tools and Resources

    Fiber photometry has become a popular technique to measure neural activity in vivo, but common analysis strategies can reduce the detection of effects because they condense within-trial signals into summary measures, and discard trial-level information by averaging across-trials. We propose a novel photometry statistical framework based on functional linear mixed modeling, which enables hypothesis testing of variable effects at every trial time-point, and uses trial-level signals without averaging. This makes it possible to compare the timing and magnitude of signals across conditions while accounting for between-animal differences. Our framework produces a series of plots that illustrate covariate effect estimates and statistical significance at each trial time-point. By exploiting signal autocorrelation, our methodology yields joint 95% confidence intervals that account for inspecting effects across the entire trial and improve the detection of event-related signal changes over common multiple comparisons correction strategies. We reanalyze data from a recent study proposing a theory for the role of mesolimbic dopamine in reward learning, and show the capability of our framework to reveal significant effects obscured by standard analysis approaches. For example, our method identifies two dopamine components with distinct temporal dynamics in response to reward delivery. In simulation experiments, our methodology yields improved statistical power over common analysis approaches. Finally, we provide an open-source package and analysis guide for applying our framework.